Company Overview

TD is a venture capital firm that specializes in the health care industry and has earned top-quartile rates of return on behalf of its investors. This performance is driven by disciplined due diligence and superior management of investments, coupled with a team approach to deal sourcing, structuring and management. Within health care, TD focuses on several segments:

• Biotechnology and life sciences
• Pharmaceuticals
• Health care services
• Medical devices

Through its national and regional presence, TD has established, funded and assisted in the growth of dozens of public and private companies with revenues ranging from zero into the billions of dollars. The firm fosters active cross-fertilization opportunities among its portfolio companies through its annual CEO conference, board membership opportunities for CEOs on other portfolio company boards, and the cultivation of relationships and new ideas among management teams.

Over the last 20 years, TD's team of accomplished business professionals has led many investments to successful outcomes, including Adams Respiratory Therapeutics (NasdaqGS: ARXT), PSS World Medical (NasdaqGM: PSSI), QuadraMed (AMEX: QD), and ViaCell (NasdaqGM: VIAC).